Scancell Holdings (SCLP.L) and Neuphoria Therapeutics (NEUP) agreed to an all-share merger to form a combined company under the Scancell name. The new entity plans to seek a Nasdaq listing under the ticker “SCLT,” which could improve liquidity and visibility. Near-term market impact is likely focused on the involved small-cap biotech names rather than broader markets.
Scancell Holdings (SCLP.L) and Neuphoria Therapeutics (NEUP) agreed to an all-share merger to form a combined company under the Scancell name. The new entity plans to seek a Nasdaq listing under the ticker “SCLT,” which could improve liquidity and visibility. Near-term market impact is likely focused on the involved small-cap biotech names rather than broader markets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
